Received Oct 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
The other one was awful; Not going to get the last one; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feels awful in a patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. The patient received the 1st dose of Shingrix and did not receive the 2nd dose of Shingrix. After receiving Shingrix and not applicable after receiving Shingrix, the patient experienced feels awful (Verbatim: The other one was awful) and incomplete course of vaccination (Verbatim: Not going to get the last one). The outcome of the feels awful was not reported and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the feels awful to be related to Shingrix. It was unknown if the company considered the feels awful to be related to Shingrix. Additional Information: GSK Receipt Date: 16-OCT-2025 The batch number was not provided, and we are unable to contact the reporter.